[Current status of the therapy of granulomatous skin infections].
We report on granulomatous infections of the skin, as well as the current state of therapeutics. Cutaneous tuberculosis and presently desired therapeutic regiments are treated in detail. Diseases regarded as eradicated in Germany, such as brucellosis and listeriosis, do still occur. Their recognition and cure are discussed from a modern point of view.
D000995:Antitubercular Agents / Q000627:therapeutic use; D003881:Dermatomycoses / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006099:Granuloma / Q000188:drug therapy*; D006801:Humans; D007896:Leishmaniasis / Q000188:drug therapy; D007917:Leprostatic Agents / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy; D008826:Microbial Sensitivity Tests; D009165:Mycobacterium Infections, Nontuberculous / Q000188:drug therapy; D010406:Penicillins / Q000627:therapeutic use; D012532:Scabies / Q000188:drug therapy; D012874:Skin Diseases, Infectious / Q000188:drug therapy*; D013591:Syphilis, Cutaneous / Q000188:drug therapy; D014123:Toxoplasmosis / Q000188:drug therapy; D014382:Tuberculosis, Cutaneous / Q000188:drug therapy
D000995:Antitubercular Agents; D007917:Leprostatic Agents; D010406:Penicillins
Derzeitiger Stand der Therapie granulomatöser Hautinfektionen.